Business Update - First nine months of the 2018/2019 financial year

21/02/2019 - 07:00 | Financial

In addition to the publication of half-year and annual results, Gimv provides an update of its activities and of the most important developments on a quarterly basis. The figures below (IFRS, consolidated, unaudited) cover the period from 1 April 2018 to 31 December 2018.

Managing Director Koen Dejonckheere:
"In the third quarter, we continued our growth: Gimv invested over EUR 100 million in promising new participations and some portfolio companies realised strategic buy-and-build acquisitions. This resulted in a further expansion of our young and promising portfolio. The IFRS valuation of the portfolio was impacted by lower market multiples due to a weak stock market evolution at the end of 2018."

NAV: EUR 1 253.6 million
In the first nine months of the current financial year, the shareholders’ equity increased from EUR 1 210.7 million (adjusted for the dividend payout) to EUR 1 253.6 million on 31 December 2018 or, per share, from EUR 47.6 to EUR 49.3.

Investments: EUR 181.4 million in 9 months​ - Active investment period
Gimv realised 4 new investments in the third quarter, for a total amount of over EUR 100 million:

  • La Comtoise (Connected Consumer): French company, develops and supplies tailor-made cheese solutions for the food industry.
  • Groupe Claire (Sustainable Cities): French group, specialist in connections, metering and fittings for drinking water supply. Also develops tailored and innovative products and solutions for network monitoring and control.
  • Medi-Markt (Health & Care): German service provider in incontinence care.
  • Camel-IDS (Health & Care): Belgian biotech company, develops radio-immunotherapeutic drugs for breast cancer patients. One of the biggest financing rounds in European biotech in 2018.

Divestments: EUR 142.1 million in 9 months 
In the third quarter, Gimv realised the successful exit of Walkro, producer of high-quality substrate for mushroom growers around the world. Walkro's stake was sold to the Irish Monaghan Mushrooms - the sole shareholder - with activities in the full range of fresh mushrooms.


Portfolio: Increase from EUR 960 million to EUR 1 060 million (+10%) in 9 months 

Value creation via buy-and-build
In line with our strategy of sustainable value creation by building strong companies, several of our portfolio companies realised significant add-on acquisitions in the past quarter, in some cases financed with an additional capital injection from Gimv.

La Croissanterie marked a strategic step by merging with Groupe Rush (Maison Pradier and Roberta), Wemas realised its second add-on in 2018 through the acquisition of Landwehr Schilderfabrik, Summa completed the acquisition of CadCam Technology and finally also Snack Connection was very active in the field of buy-and-build.

Strong portfolio growth
Both the intensive investment activity, the persistent value creation through buy-and-build and the good portfolio performance resulted in a strong growth of the portfolio by 10% in the first nine months of the financial year to EUR 1 060 million. On the other hand, the weak stock market evolution at the end of 2018 had a negative impact on the IFRS valuation of the portfolio through the lower market multiples. The negative valuation impact amounted to approximately EUR 28 million in the third quarter.

Read all press releases